{
    "clinical_study": {
        "@rank": "142858", 
        "arm_group": [
            {
                "arm_group_label": "AN 69 ST hemofilter", 
                "arm_group_type": "Experimental", 
                "description": "Use AN 69 ST hemofilter during CRRT"
            }, 
            {
                "arm_group_label": "AN 69 hemofilter", 
                "arm_group_type": "Active Comparator", 
                "description": "Use AN 69 hemofilter during CRRT"
            }
        ], 
        "brief_summary": {
            "textblock": "Compared with AN69 hemofilter, AN69 ST hemofilter may prolong the time of hemofilter and\n      decrease the quantity of heparin during continuous renal replacement therapy in critically\n      ill."
        }, 
        "brief_title": "Effects of AN69 ST Hemofilter on Coagulation During Continuous Renal Replacement Therapy in Critically Ill", 
        "condition": [
            "Critically Ill", 
            "Acute Kidney Injury", 
            "Septic Shock"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Critical Illness", 
                "Acute Kidney Injury", 
                "Shock", 
                "Shock, Septic", 
                "Wounds and Injuries"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age> 18 years old\n\n          -  admitted to ICU and need CRRT\n\n          -  anticipated survival time >72h\n\n        Exclusion Criteria:\n\n          -  allergy to hemofilter or heparin\n\n          -  heparin associated thrombocytopenia\n\n          -  pregnancy or lactation\n\n          -  using other anticoagulate drugs"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01823484", 
            "org_study_id": "112233"
        }, 
        "intervention": [
            {
                "arm_group_label": "AN 69 ST hemofilter", 
                "intervention_name": "AN 69 ST hemofilter", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "AN 69 hemofilter", 
                "intervention_name": "AN 69 hemofilter", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "hemofilter", 
            "coagulation", 
            "CRRT", 
            "critically ill"
        ], 
        "lastchanged_date": "January 13, 2014", 
        "location": {
            "contact": {
                "email": "xiaohua0917@163.com", 
                "last_name": "Qiu Xiaohua", 
                "phone": "02583262553"
            }, 
            "facility": {
                "address": {
                    "city": "Nanjing", 
                    "country": "China", 
                    "state": "Jiangsu", 
                    "zip": "210009"
                }, 
                "name": "Xiaohua Qiu"
            }, 
            "investigator": {
                "last_name": "Qiu Xiaohua", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effects of AN69 ST Hemofilter on Coagulation During Continuous Renal Replacement Therapy in Critically Ill", 
        "other_outcome": {
            "measure": "Number of participants with adverse events during  continuous renal replacement therapy", 
            "safety_issue": "Yes", 
            "time_frame": "72h"
        }, 
        "overall_contact": {
            "email": "xiaohua0917@163.com", 
            "last_name": "Qiu Xiaohua", 
            "phone": "02583262553"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ethics Committee"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The time from the beginning of continuous renal replacement therapy until to the end when continuous renal replacement therapy had to be finished because of clotting or other reasons", 
            "measure": "The using time of hemofilters", 
            "safety_issue": "No", 
            "time_frame": "72h"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01823484"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Zhongda Hospital", 
            "investigator_full_name": "Xiaohua Qiu", 
            "investigator_title": "physician", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Heparin will be used according to activated partial thromboplastin time, and the quantity will be recorded.", 
            "measure": "activated partial thromboplastin time", 
            "safety_issue": "No", 
            "time_frame": "every 6h from the begining of continuous renal replacement therapy,up to 72h"
        }, 
        "source": "Zhongda Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Zhongda Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}